MedPath
FDA Approval

Meclizine Hydrochloride

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
September 8, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Meclizine(25 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

NuCare Pharmaceuticals,Inc.

NuCare Pharmaceuticals,Inc.

010632300

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Meclizine Hydrochloride

Product Details

NDC Product Code
68071-2697
Application Number
ANDA084657
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
September 8, 2022
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MICROCRYSTALLINE CELLULOSE 102Inactive
Code: PNR0YF693YClass: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8Class: IACT
HYDROGENATED COTTONSEED OILInactive
Code: Z82Y2C65EAClass: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2Class: IACT
D&C YELLOW NO. 10 ALUMINUM LAKEInactive
Code: CQ3XH3DET6Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
MeclizineActive
Code: HDP7W44CIOClass: ACTIBQuantity: 25 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath